期刊文献+

Two-year delay in ulcerative colitis diagnosis is associated with anti-tumor necrosis factor alpha use 被引量:4

Two-year delay in ulcerative colitis diagnosis is associated with anti-tumor necrosis factor alpha use
下载PDF
导出
摘要 BACKGROUND Ulcerative colitis(UC)is an uncommon inflammatory bowel disease(IBD).However,its incidence has recently increased in South Korea.Moreover,UC diagnoses are frequently delayed,and the relationship between diagnostic delay and UC prognosis has not been extensively studied in South Korean patients.AIM To identify meaningful diagnostic delay affecting UC prognosis and to evaluate risk factors associated with diagnostic delay in South Korean patients.METHODS Medical records of 718 patients with UC who visited the outpatient clinic of six university hospitals in South Korea were reviewed;167 cases were excluded because the first symptom date was unknown.We evaluated the relationship between the prognosis and a diagnostic delay of 3,6,12,18,and 24 mo by comparing the prognostic factors[anti-tumor necrosis factor(TNF)-αuse,admission history due to acute flare-ups,frequent admission due to flare-ups,surgery associated with UC,and the clinical remission state at the latest followup]at each diagnostic interval.RESULTS The mean diagnostic interval was 223.3±483.2 d(median,69 d;75th percentile,195 d).Among the prognostic factors,anti-TNFαuse was significantly increased after a diagnostic delay of 24 mo.Clinical risk factors predictive of a 24-mo diagnostic delay were age<60 years at diagnosis[odd ratio(OR)=14.778,95%confidence interval(CI):1.731-126.121],smoking history(OR=2.688,95%CI:1.239-5.747,P=0.012),and misdiagnosis of hemorrhoids(OR=11.066,95%CI:3.596-34.053).Anti-TNFαuse was associated with extensive UC at diagnosis(OR=3.768,95%CI:1.860-7.632)and 24-mo diagnostic delay(OR=2.599,95%CI:1.006-4.916).CONCLUSION A diagnostic delay>24 mo was associated with increased anti-TNFαuse.Age<60 years at diagnosis,smoking history,and misdiagnosis of hemorrhoids were risk factors for delayed diagnosis. BACKGROUND Ulcerative colitis(UC) is an uncommon inflammatory bowel disease(IBD).However, its incidence has recently increased in South Korea. Moreover, UC diagnoses are frequently delayed, and the relationship between diagnostic delay and UC prognosis has not been extensively studied in South Korean patients.AIM To identify meaningful diagnostic delay affecting UC prognosis and to evaluate risk factors associated with diagnostic delay in South Korean patients.METHODS Medical records of 718 patients with UC who visited the outpatient clinic of six university hospitals in South Korea were reviewed; 167 cases were excluded because the first symptom date was unknown. We evaluated the relationship between the prognosis and a diagnostic delay of 3, 6, 12, 18, and 24 mo by comparing the prognostic factors [anti-tumor necrosis factor(TNF)-α use,admission history due to acute flare-ups, frequent admission due to flare-ups,surgery associated with UC, and the clinical remission state at the latest followup] at each diagnostic interval.RESULTS The mean diagnostic interval was 223.3 ± 483.2 d(median, 69 d; 75 th percentile,195 d). Among the prognostic factors, anti-TNFα use was significantly increased after a diagnostic delay of 24 mo. Clinical risk factors predictive of a 24-mo diagnostic delay were age < 60 years at diagnosis [odd ratio(OR) = 14.778, 95%confidence interval(CI): 1.731-126.121], smoking history(OR = 2.688, 95%CI:1.239-5.747, P = 0.012), and misdiagnosis of hemorrhoids(OR = 11.066, 95%CI:3.596-34.053). Anti-TNFα use was associated with extensive UC at diagnosis(OR= 3.768, 95%CI: 1.860-7.632) and 24-mo diagnostic delay(OR = 2.599, 95%CI:1.006-4.916).CONCLUSION A diagnostic delay > 24 mo was associated with increased anti-TNFα use. Age <60 years at diagnosis, smoking history, and misdiagnosis of hemorrhoids were risk factors for delayed diagnosis.
出处 《World Journal of Gastroenterology》 SCIE CAS 2019年第8期989-1001,共13页 世界胃肠病学杂志(英文版)
关键词 ULCERATIVE colitis Diagnostic DELAY ANTI-TUMOR NECROSIS factor ALPHA SMOKING Ulcerative colitis Diagnostic delay Anti-tumor necrosis factor alpha Smoking
  • 相关文献

参考文献1

二级参考文献39

  • 1[1]Scaldaferri F,Fiocchi C.Inflammatory bowel disease:progress and current concepts of etiopathogenesis.J Dig Dis 2007; 8:171-178
  • 2[2]Cosnes J,Nion-Larmurier I,Beaugerie L,Afchain P,Tiret E,Gendre JP.Impact of the increasing use of mmunosuppressants in Crohn's disease on the need for intestinal surgery.Gut 2005; 54:237-241
  • 3[3]Dubinsky MC.Azathioprine,6-mercaptopurine in inflammatory bowel disease:pharmacology,efficacy,and safety.Clin Gastroenterol Hepatol 2004; 2:731-743
  • 4[4]Siegel CA,Sands BE.Review article:practical management of inflammatory bowel disease patients taking immunomodulators.Aliment Pharmacol Ther 2005; 22:1-16
  • 5[5]Su C,Lichtenstein GR.Treatment of inflammatory bowel disease with azathioprine and 6-mercaptopurine.Gastroenterol Clin North Am 2004; 33:209-234,viii
  • 6[6]Sandborn W,Sutherland L,Pearson D,May G,Modigliani R,Prantera C.Azathioprine or 6-mercaptopurine for inducing remission of Crohn's disease.Cochrane Database Syst Rev 2000; CD000545
  • 7[7]Pearson DC,May GR,Fick G,Sutherland LR.Azathioprine for maintaining remission of Crohn's disease.Cochrane Database Syst Rev 2000;CD000067
  • 8[8]Present DH,Meltzer SJ,Krumholz MP,Wolke A,Korelitz BI.6-Mercaptopurine in the management of inflammatory bowel disease:short-and long-term toxicity.Ann Intern Med 1989; 111:641-649
  • 9[9]Gisbert JP,Gonzelez-Lama Y,Mate J.Thiopurine-induced liver injury in patients with inflammatory bowel disease:a systematic review.Am J Gastroentero12007; 102:1518-1527
  • 10[10]Masunaga Y,Ohno K,Ogawa R,Hashiguchi M,Echizen H,Ogata H.Meta-analysis of risk of malignancy with immunosuppressive drugs in inflammatory bowel disease.Ann Pharmacother 2007; 41:21-28

共引文献9

同被引文献32

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部